DiaMedica Therapeutics Inc. (DMAC)

NASDAQ: DMAC · Real-Time Price · USD

5.33

-0.09 (-1.66%)

At close: Jun 10, 2026, 4:00 PM EDT

5.12

-0.21 (-3.94%)

After-hours: Jun 10, 2026, 4:28 PM EDT

DiaMedica Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4.87	15.65	3.03	4.54	4.73	4.71
Short-Term Investments	46.46	44.24	41.12	48.35	28.77	40.41
Cash & Short-Term Investments	51.33	59.89	44.15	52.9	33.5	45.11
Cash Growth	41.33%	35.66%	-16.54%	57.89%	-25.74%	64.00%
Accounts Receivable	0.3	0.26	0.24	0.37	0.08	0.13
Other Current Assets	0.73	0.48	0.23	0.41	0.25	0.2
Total Current Assets	52.36	60.63	44.61	53.68	33.84	45.44
Net Property, Plant & Equipment	0.32	0.34	0.43	0.49	0.56	0.11
Other Long-Term Assets	0.4	0.4	1.31	-	-	-
Total Assets	53.08	61.37	46.35	54.16	34.4	45.55
Accounts Payable	3.29	1.48	0.94	0.93	0.73	0.51
Accrued Expenses	2.34	3.55	4.35	1.78	1.37	0.97
Current Portion of Leases	0.12	0.11	0.1	0.08	0.07	0.05
Total Current Liabilities	5.75	5.13	5.39	2.79	2.17	1.52
Long-Term Leases	0.1	0.13	0.24	0.32	0.4	0
Total Long-Term Liabilities	0.1	0.13	0.24	0.32	0.4	0
Total Liabilities	5.85	5.26	5.63	3.1	2.57	1.53
Additional Paid-in Capital	230.07	228.83	180.7	166.61	128.08	126.58
Accumulated Other Comprehensive Income	-0.03	0.05	0.02	0.01	-0.07	-0.05
Retained Earnings	-	-172.77	-140	-115.56	-96.18	-82.5
Shareholders' Equity	47.24	56.11	40.72	51.06	31.83	44.02
Total Liabilities & Equity	53.08	61.37	46.35	54.16	34.4	45.55
Total Debt	0.21	0.24	0.34	0.4	0.47	0.05
Net Cash (Debt)	51.12	59.65	43.81	52.5	33.03	45.06
Net Cash Growth	-14.30%	36.17%	-16.55%	58.92%	-26.69%	64.52%
Net Cash Per Share	1.03	1.27	1.08	1.61	1.25	2.17
Book Value	47.24	56.11	40.72	51.06	31.83	44.02
Book Value Per Share	0.95	1.19	1.01	1.57	1.20	2.12
Tangible Book Value	47.24	56.11	40.72	51.06	31.83	44.02
Tangible Book Value Per Share	0.95	1.19	1.01	1.57	1.20	2.12

SEC Filings: 10-K · 10-Q